what type of drug is tirzepatide FDA approves tirzepatide, Eli Lilly's

2 Reward Eating, GLP-1 and Estrogen Reward eating is comprised of two categories, wanting and liking. 5 Liking is associated with the palatability of the food and wanting is food craving triggered by a cue or stimuli which then leads to motivation to obtain a specific type of food

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD

There were no deaths considered related to the study treatment.In conclusion, tirzepatide demonstrated superior efficacy compared to titrated insulin degludec in individuals with type 2 diabetes, as evidenced by greater reductions in HbA1c and body weight at week 52 and a lower risk of hypoglycemia

Long-Term Tolerance Still Matters Side effects should not be dismissed simply because treatment has continued for several months

doi: 10.1038/s41591-022-02026-4 Summary Keywords obesity, molecular mechanism, semaglutide, liraglutide, weight loss Citation Tamayo-Trujillo R, Ruiz-Pozo VA, Cadena-Ullauri S, Guevara-Ramrez P, Paz-Cruz E, Zambrano-Villacres R, Simancas-Racines D and Zambrano AK (2024) Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity